With A Delayed Vaccine And New Virus Variants Emerging, Where Does Novavax Stock Stand?

Covid-19 vaccine developer Novavax's stock rallied by about 4% over the last three trading days, while rising by almost 8% in Tuesday's trading, following the discovery of a highly mutated new strain of the novel coronavirus that has been designated as a variant of concern by the World Health...